HIGHLIGHTS
- who: Michele Malagola from the American University of Beirut Medical Hospital, Italy have published the Article: Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol), in the Journal: (JOURNAL)
- what: The aim of this retrospective study was to assess the efficacy of the BATMO program in terms of OS. The authors focused on BSIs that occurred in 162 allotransplanted patients. In this analysis, the authors compared the distribution and outcome of infectious complications recorded between 2019 and 2021 (Cohort B), with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.